Skip to main content
. 2024 Feb 14;14:3713. doi: 10.1038/s41598-024-54186-7

Table 3.

External validation of TransXAI on FeTS2022 challenge datasets.

Institute Number of cases BraTS 2019 Overlap DSC HD95
ET TC WT Avg ET TC WT Avg
1 511 129 0.710 0.891 0.739 0.780 4.68 14.95 7.88 9.17
2 6 0.638 0.913 0.646 0.732 8.01 10.69 14.14 10.95
18 382 0.687 0.854 0.718 0.753 6.20 16.77 9.04 10.67
20 33 0.759 0.946 0.784 0.830 4.69 7.15 7.43 6.42
21 35 0.804 0.931 0.800 0.845 6.46 9.12 8.68 8.09
22 7 0.778 0.897 0.823 0.833 5.29 13.66 7.30 8.75

DSC and HD95 are reported for enhancing tumor (ET), tumor core (TC), and whole tumor (WT), along with their average (Avg) values for each institute.

HHS Vulnerability Disclosure